A case against body Detox and for Modified Citrus Pectin
You may be under the impression that a detoxing program will good for your health. You might have read or been told that a detox can remove pesticides, chemicals and heavy metals from your body. You may have also heard how it can upgrade your immune system and bring new health to your liver.
But here is something you may not know; Detox programs, by forcing toxins to move from your fat cells [where most are stored and contained] to your blood stream, can actually make your body more toxic and make you feel sicker!
Detoxification experts will tell you that these symptoms can be taken to mean that your detox was effective, and that your body is healing. Often they will refer to this stage as the ‘healing crisis’ and they will tell you that the symptoms are caused by the removal of certain, harmful substances your body has grown used to and dependent on.
There are approximately 200 times more toxins stored in your fat cells than in your blood and while these toxins are trapped in your fat cells, they are contained.
When you undergo a detox program these toxins are forced out of your fat cells and into your bloodstream. Once they move into your bloodstream, they are free to travel throughout your body and into your vital organs causing symptoms which make you feel worse, not better!
- The brain can retain the freed toxins causing headaches, memory loss, and premature brain aging.
- They can enter your heart where they can cause blood pressure problems.
- The toxins can invade your pancreas where they can cause blood sugar problems.
- Vision problems can come from toxins being absorbed in the eyes.
- When they enter your stomach they can cause nausea or vomiting.
That’s why detoxification programs often cause more health problems than they solve. And it’s why so many people who go on a detox program end up feeling worse afterwards!
If you want to work at removing toxins from your system there is another, easier way you can try using Modified Citrus Pectin.
What is Modified Citrus Pectin?
Other common name(s): citrus pectin, Pecta-Sol®, MCP
Scientific/medical name(s): none
Modified citrus pectin (MCP) is a form of pectin that has been altered so that it can be more easily absorbed by the digestive tract. Pectin is a carbohydrate that is made of hundreds or thousands of sugar molecules chemically linked together. It is found in most plants and is particularly plentiful in the peels of apples, citrus fruits, and plums. In modified citrus pectin, the pectin has been chemically altered to break its molecules into smaller pieces. Pectin in its natural form cannot be absorbed by the body and is considered a type of soluble dietary fiber, whereas modified pectin can be absorbed into the bloodstream.
Animal studies and a couple of uncontrolled human studies have found that MCP may inhibit the spread of prostate cancer and melanoma to other organs. However, there have been no controlled clinical studies to prove this effect in humans.
How is it promoted for use?
Proponents claim that modified citrus pectin slows or stops the growth of melanoma, a dangerous form of skin cancer, and metastatic prostate cancer (prostate cancer that has spread). Some also claim that a compound found in MCP strengthens the cancer cell–killing ability of T-cells, cells that also protect against germs.
What does it involve?
Modified citrus pectin is available as a capsule or a powder. The dose suggested by manufacturers for the powder is 5 grams (nearly a fifth of an ounce) mixed with water or juice taken 3 times a day with meals. For capsules, the suggested dose is 800 milligrams (mg) 3 times a day with meals.
What is the history behind it?
Pectin is commonly used as a gelling agent for canning foods and making jellies. It is also used widely in the production of food and cosmetics and as an ingredient in some anti-diarrhea medicines. In the past 10 years, the modified form of pectin has been investigated for anti-cancer properties.
What is the evidence?
Several animal studies found that MCP helped reduce the spread of prostate, breast, and skin cancer. Animals with these types of cancer that were fed MCP had a much lower risk of the tumor spreading to the lungs. For example, one study examined the effects of MCP on lung metastases from melanoma cells. Researchers injected mice with melanoma cells. In the mice that were also given MCP, significantly fewer tumors spread to the lungs than in the mice that did not receive the drug. When lung tumors did develop in the mice treated with MCP, the tumors tended to be smaller than those that formed in untreated animals.
These studies appear to show that MCP makes it difficult for cancer cells that break off from the main tumor to join together and grow in other organs. However, in most animal studies, MCP had no effect on the main tumor, suggesting that it may only be useful for preventing or slowing the growth of metastatic tumors in very early stages of development.
Recent laboratory studies of human and animal cells have provided information on how MCP might slow the spread of cancer. MCP appears to attach to galectin-3, a common chemical in many cells. Galectin-3 is present in abnormally high levels in many cancers and plays an important role in the growth, survival, and spread of cancer cells.
Although animal and cell studies are quite encouraging, very little information is available about whether MCP is effective in humans. In one published clinical trial, 10 men with prostate cancer were treated with MCP after standard treatment failed. In 7 of these men, blood tests found prostate-specific antigen (PSA, a marker of prostate cancer growth). Their PSA doubling time (a measure of how fast PSA goes up) improved in comparison with measurements done before taking MCP, indicating that MCP may have a slowing effect on the cancer’s growth.
This study had no control group (in this case, a group of men who did not take MCP), which limits the strength of its conclusions on MCP’s effectiveness. It also did not measure survival or other important endpoints. However, taken with the information gained from animal studies, it suggests that MCP may have a role in reducing the growth and spread of cancer. Randomized controlled trials looking at larger groups of people must be done before any firmer conclusions can be reached.
Are there any possible problems or complications?
This product is sold as a dietary supplement in the United States. Unlike drugs (which must be tested before being allowed to be sold), the companies that make supplements are not required to prove to the Food and Drug
Administration that their supplements are safe or effective, as long as they don’t claim the supplements can prevent, treat, or cure any specific disease.
Some such products may not contain the amount of the herb or substance that is written on the label, and some may include other substances (contaminants). Actual amounts per dose may vary between brands or even between different batches of the same brand.
Most such supplements have not been tested to find out if they interact with medicines, foods, or other herbs and supplements. Even though some reports of interactions and harmful effects may be published, full studies of interactions and effects are not often available. Because of these limitations, any information on ill effects and interactions below should be considered incomplete.
Citrus pectin is categorized as “generally regarded as safe” by the U.S. Food and Drug Administration, When MCP is used as intended, side effects rarely occur. However, some people may experience stomach discomfort after taking MCP. There have been a few case reports in which asthma developed in people after exposure to powdered pectin. Modified citrus pectin may cause serious allergic reactions in those who are allergic to citrus fruits.
Relying on this type of treatment alone and avoiding or delaying conventional medical care for cancer may have serious health consequences.